Company: GRCE
Filing Date: 2025-11-13
Form Type: 10-Q
Source: 0001140361-25-041804
Chunk: 48

Company: Grace Therapeutics, Inc.
Filing Date: 2025-11-13
Form: 10-Q
Item: Item 8
Chunk 48
---
 Exchange Act of 1934

      32.1*

      Certification of the Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

      32.2*

      Certification of the Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

      101.INS

      Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document

      101.SCH

      Inline XBRL Taxonomy Extension Schema With Embedded Linkbase Documents

      104

      Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

   * Filed or furnished herewith

   † Indicates a management contract or compensatory plan.

   # Filed herewith solely to reflect the name change of the Company from Acasti Pharma Inc. to Grace Therapeutics, Inc.

  38
  

   SIGNATURES

   Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

      Dated: November 13, 2025

      GRACE THERAPEUTICS, INC.

      By:

      /s/ Prashant Kohli

      Name: Prashant Kohli

      Title: Chief Executive Officer (Principal Executive Officer)

      By:

      /s/ Robert DelAversano

      Name: Robert DelAversano

      Title: Principal Financial Officer (Principal Financial Officer)

39

http://fasb.org/us-gaap/2025#FairValueAdjustmentOfWarrants
http://fasb.org/us-gaap/2025#FairValueAdjustmentOfWarrants
0001444192
false
2026
Q2
--03-31

    0001444192

    2025-04-01
    2025-09-30

    0001444192

    2025-11-13

    0001444192

    2025-09-30

    0001444192

    2025-03-31